Rituximab with plasmapheresis and splenectomy in ABO-incompatible liver transplantation

被引：43

作者：

Monteiro, I

McLoughlin, LM

Fisher, A

De la Torre, AN

Koneru, B

机构：

[1] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA

[2] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Pediat, Newark, NJ 07103 USA

来源：

TRANSPLANTATION | 2003年 / 76卷 / 11期

关键词：

D O I：

10.1097/01.TP.0000082723.02477.87

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1648 / 1649

页数：2

共 5 条

[1] THE USE OF ABO-INCOMPATIBLE GRAFTS IN LIVER-TRANSPLANTATION - A LIFESAVING PROCEDURE IN HIGHLY SELECTED PATIENTS [J].

FARGES, O ;

KALIL, AN ;

SAMUEL, D ;

SALIBA, F ;

ARULNADEN, JL ;

DEBAT, P ;

BISMUTH, A ;

CASTAING, D ;

BISMUTH, H .

TRANSPLANTATION, 1995, 59 (08) :1124-1133

[2]

FISCHEL RJ, 1989, TRANSPLANT P, V21, P2221

[3] Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab [J].

Sharma, VR ;

Fleming, DR ;

Slone, SP .

BLOOD, 2000, 96 (03) :1184-1186

[4] Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder. [J].

Suzan, F ;

Ammor, M ;

Ribrag, V .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (13) :1000-1000

[5]

TOMA H, 1994, UROL CLIN N AM, V21, P299

← 1 →